Adipogenesis is the process of differentiation of adipocytes from mesenchymal multipotent cells through adipocyte precursors. In this issue, a study by the groups of Opas and Michalak (Szabo, E., Y. Qiu, S. Baksh, M. Michalak, and M. Opas. 2008. J. Cell. Biol. 182:103–116) demonstrates that this process is repressed by increasing intracellular Ca2+, which, in turn, is dependent on the expression of calreticulin, the major Ca2+-binding protein of the endoplasmic reticulum lumen.
The rise of the adipose mass, which takes place throughout animal life, is caused not only by the increase of fat cell volume but also by the differentiation of multipotent mesenchymal stem cells. So far, however, this adipogenetic process has been investigated primarily in its terminal phase, the conversion of preadipocytes into mature adipocytes. The determination phase, when stem cells make their initial choice, has been deciphered only in general terms (Rosen and MacDougald, 2006; Gesta et al., 2007). Similar to other differentiation processes, adipogenesis depends on the expression of specific genes governed by both stimulatory (primarily PPARγ and CCAAT enhancer–binding protein [C/EBP]) and repressive (the GATA family) transcription factors activated by various extracellular signals, such as TGFβ, bone morphogenic protein, Notch, and others. An increase in the cellular Ca2+ level induced by events such as incubation in high Ca2+ media (Jensen et al., 2004) and activation of receptors or channels (Liu and Clipstone, 2007; Zhang et al., 2007) has been reported to inhibit the differentiation of 3T3-L1 preadipocytes. However, these results are often overlooked, possibly because they appear incompatible with the general role most often attributed to Ca2+, the stimulation of rapid (or very rapid) events such as excitation, neurosecretion, and contraction.
In the study by Szabo et al. (see p. 103 of this issue), the role of Ca2+ in adipogenesis was reinvestigated by focusing on the general homeostasis of the cation and, in particular, on calreticulin, the major Ca2+-binding protein of the ER lumen. Because of its large capacity (∼50 mol/mole) and low affinity (Kd of ∼0.5 mM) binding, calreticulin contributes the majority of the rapidly exchanging Ca2+ pool in most cells (Bastianutto et al., 1995; Nakamura et al., 2001). Previous studies by the Opas and Michalak groups had shown calreticulin to be needed for development of the heart (Lynch et al., 2006). The new experiments on adipogenesis in embryonic stem (ES) cells have yielded just the opposite result. An astonishing increase of the adipogenic potential (30-fold) and of the number of adipocyte colonies (ninefold) was induced not by the expression but by the down-regulation of calreticulin. Because calreticulin is both a binding Ca2+ protein and a chaperone, the authors went on to confirm that the effects on adipogenesis were indeed caused by a decrease in the Ca2+ concentration of the ER lumen and cytosol. Expression of either full-length calreticulin or the C-terminal Ca2+-binding region of the protein (Nakamura et al., 2001) in the calreticulin down-regulated ES cells abolished the increase in adipogenic potential. Conversely, expression of the N-terminus chaperoning domain of the protein had no effect. Moreover, duplication of the adipogenetic results in wild-type calreticulin-expressing ES cells loaded with a Ca2+ chelator, BAPTA, revealed that the Ca2+ decrease is critical at an early checkpoint, within the first 3 d of differentiation. Finally, induction of adipogenesis in 3T3-L1 preadipocytes by exposure to retinoic acid resulted in a down-regulation of calreticulin. Therefore, Ca2+ and calreticulin appear to play a key role in the whole adipogenetic process, from the early commitment of stem cells to the late conversion of preadipocytes.
The most unexpected result of the paper by Szabo et al. (2008) dealt with the relationship between calreticulin and PPARγ2, the master transcription factor of adipogenesis. Binding of PPARγ2 to two specific sites in the calreticulin gene was found not to inhibit but to stimulate the expression of calreticulin. In addition, PPARγ2 was found to be down-regulated in cells overexpressing calreticulin. Therefore, there appears to be a negative feedback loop in which PPARγ2 stimulates the expression of calreticulin, which, in turn, inhibits the activity and expression of PPARγ2. As a consequence, as long as the stem cells are not stimulated, their high calreticulin prevents their commitment to adipocyte differentiation. The enzyme that appears to mediate the inhibitory action of calreticulin is calcineurin, a well-known Ca2+-dependent protein phosphatase that in other cell types is known to govern the translocation of specific transcription factors to the nucleus (Tomida et al., 2003; Colella et al., 2008). The differentiation of ES cells is also governed by a well-known Ca2+-dependent enzyme, Ca2+/calmodulin-dependent protein kinase II (CaMKII). In this case, however, CaMKII appears to be activated not by Ca2+ but by c-Srk. Phosphorylation by CaMKII results in the activation of PPARγ2 and cAMP response element binding, a Ca2+-independent transcription factor necessary for activation of the other key regulator of adipogenesis, C/EBPα. Thus, in this case, CaMKII appears to provide a Ca2+-independent pathway for stimulating adipogenesis.
The results by Szabo et al. (2008) provide a comprehensive picture of Ca2+ and adipogenesis, revealing a variety of cellular aspects that so far have remained undefined (Fig. 1). In view of the properties of stem cells and adipocytes, the key role of the ER Ca2+ store and, therefore, of calreticulin is not surprising. More unexpected was the involvement of Ca2+ in the control of the whole differentiation process, from multipotent mesenchymal cells to adipocytes, and the complexity of its connection with the classic transcription factors. These results reveal a new long-term repressive role for calreticulin that is necessary to prevent the commitment of mesenchymal stem cells to adipocyte differentiation. The inhibitory role of Ca2+ in adipogenesis is also surprising. Ca2+ is known to participate in the regulation of a huge number of processes that are rapid and also slow, such as cell growth. In most of these cases, however, the role of Ca2+ is stimulatory. Also unexpected are the opposite roles of the two Ca2+-dependent enzymes, calcineurin and CaMKII; the first role in working to mediate the inhibition of adipogenesis, and the second role as a key activator. Although the activation of CaMKII by Srk-induced tyrosine phosphorylation of calmodulin was known (Corti et al., 1999), to my knowledge, the stimulation by CaMKII of a Ca2+-inhibited process is new.
Inevitably, quite a number of questions remain open. These include understanding the process by which retinoic acid induces the differentiation of wild-type stem cells that are rich in calreticulin and poor in PPARγ2; deciphering the opposite roles of calreticulin and Ca2+ on differentiation of the heart (stimulatory) and adipocytes (inhibitory); and finding the substrates of CaMKII necessary for differentiation and the mechanisms of action of calcineurin (possibly via translocation of transcription factors).
Adipose tissue has long been one of the least investigated systems of the body. Interest has increased considerably since its identification as the largest endocrine system, participating in the control of processes as diverse as blood pressure, immune function, angiogenesis, and energy balance. Concomitantly, the epidemic surge of obesity and type 2 diabetes, with their fallout of morbidity and mortality, has called attention to adipogenesis. The identification of specific Ca2+-dependent aspects of the process therefore appears timely. After all, the efficacy of Ca2+-rich diets against obesity is known both in mouse and man (Shi et al., 2001; Zemel et al., 2004). The results of Szabo et al. (2008) could now help to find specific targets to which new investigative and therapeutic tools could be addressed.
© 2008 Meldolesi This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).